Post-treatment positron emission tomography-computed tomography is highly predictive of outcome in Plasmablastic lymphoma View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2018-09

AUTHORS

Yassine Al Tabaa, Emmanuelle Tchernonog, Pierre Faurie, Anne Ségolène Cottereau, Hélène Monjanel, Antoine Bonnet, Steven Le Gouill, Emmanuel Gyan, Hervé Ghesquieres, Denis Mariano-Goulart, Guillaume Cartron

ABSTRACT

PURPOSE: Plasmablastic lymphoma (PBL) is a rare variant of diffuse large B cell lymphomas (DLBCL) clinically characterized by a poorer prognostic. Few clinical and imaging data are available and derived from pooled case reports and small series. The aim of the study was to evaluate the FDG avidity at baseline and the utility of 18-Fluorodeoxyglucose (FDG) positron-emission-tomography/computed-tomography (PET/CT) for staging and response assessment. METHODS: Patients with newly diagnosed PBL seen at Lymphoma Study Association centers during the period 2005-2015 were included if they underwent a PET/CT at staging and at the end of treatment (eotPET) and had received an anthracycline-based first line therapy. EotPET scans were analyzed using the 5-point-scale visual analysis in accordance with Lugano criteria. Patients were classified in complete metabolic response (CMR) or no-CMR including partial metabolic response (PMR), stable disease (SD) and progression disease (PD). EotPET results were assessed for the ability to predict event free survival (EFS) and overall survival (OS). RESULTS: Thirty-five PBL patients fulfilled the inclusion criteria. The median follow-up was 34 months (2.8-120 months). FDG avidity was found in all patients at diagnosis. Most patients (80%) achieved CMR, and 20% were no-CMR including 9% PMR, 6% SD, and 6% PD. A CMR after first line chemotherapy predicted higher EFS (p < 0.0001) and OS (p = 0.0006). CONCLUSIONS: This study confirmed the FDG avidity of PBL subtype and the usefulness of PET/CT scanning in restaging an aggressive lymphoma at the completion of chemotherapy. EotPET can predict outcomes following treatment in patients with PBL. More... »

PAGES

1705-1709

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s00259-018-4020-5

DOI

http://dx.doi.org/10.1007/s00259-018-4020-5

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1103493485

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/29679112


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Clinical Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adolescent", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adult", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aged, 80 and over", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Fluorodeoxyglucose F18", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Image Processing, Computer-Assisted", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Middle Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Plasmablastic Lymphoma", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Positron Emission Tomography Computed Tomography", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Prognosis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Retrospective Studies", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Survival Analysis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Treatment Outcome", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Young Adult", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "University Hospital of Montpellier", 
          "id": "https://www.grid.ac/institutes/grid.157868.5", 
          "name": [
            "Department of Nuclear Medicine, CHU Montpellier, 80 Avenue Augustin Fliche, 34095, Montpellier, Cedex 05, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Al Tabaa", 
        "givenName": "Yassine", 
        "id": "sg:person.01130727257.14", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01130727257.14"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University Hospital of Montpellier", 
          "id": "https://www.grid.ac/institutes/grid.157868.5", 
          "name": [
            "Department of Hematology, University Hospital of Montpellier, UMR CNRS 5235, Montpellier, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Tchernonog", 
        "givenName": "Emmanuelle", 
        "id": "sg:person.01326064671.60", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01326064671.60"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "L\u00e9on B\u00e9rard Center, Department of Hematology, Lyon, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Faurie", 
        "givenName": "Pierre", 
        "id": "sg:person.01366522606.02", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01366522606.02"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Department of Nuclear Medicine, CHU Tenon, Paris, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Cottereau", 
        "givenName": "Anne S\u00e9gol\u00e8ne", 
        "id": "sg:person.0604155154.50", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0604155154.50"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Centre Hospitalier Universitaire de Tours", 
          "id": "https://www.grid.ac/institutes/grid.411167.4", 
          "name": [
            "Department of Hematology, University Hospital of Tours, Tours, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Monjanel", 
        "givenName": "H\u00e9l\u00e8ne", 
        "id": "sg:person.01352532274.15", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01352532274.15"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Centre Hospitalier Universitaire de Nantes", 
          "id": "https://www.grid.ac/institutes/grid.277151.7", 
          "name": [
            "Department of Hematology, University Hospital of Nantes, INSERM UMR 892, Nantes, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Bonnet", 
        "givenName": "Antoine", 
        "id": "sg:person.012143174115.29", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012143174115.29"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Centre Hospitalier Universitaire de Nantes", 
          "id": "https://www.grid.ac/institutes/grid.277151.7", 
          "name": [
            "Department of Hematology, University Hospital of Nantes, INSERM UMR 892, Nantes, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Le Gouill", 
        "givenName": "Steven", 
        "id": "sg:person.015715754073.62", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015715754073.62"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Centre Hospitalier Universitaire de Tours", 
          "id": "https://www.grid.ac/institutes/grid.411167.4", 
          "name": [
            "Department of Hematology, University Hospital of Tours, Tours, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Gyan", 
        "givenName": "Emmanuel", 
        "id": "sg:person.01007177364.11", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01007177364.11"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "L\u00e9on B\u00e9rard Center, Department of Hematology, Lyon, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Ghesquieres", 
        "givenName": "Herv\u00e9", 
        "id": "sg:person.0575401352.69", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0575401352.69"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University Hospital of Montpellier", 
          "id": "https://www.grid.ac/institutes/grid.157868.5", 
          "name": [
            "Department of Nuclear Medicine, CHU Montpellier, 80 Avenue Augustin Fliche, 34095, Montpellier, Cedex 05, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Mariano-Goulart", 
        "givenName": "Denis", 
        "id": "sg:person.01370737637.53", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01370737637.53"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University Hospital of Montpellier", 
          "id": "https://www.grid.ac/institutes/grid.157868.5", 
          "name": [
            "Department of Hematology, University Hospital of Montpellier, UMR CNRS 5235, Montpellier, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Cartron", 
        "givenName": "Guillaume", 
        "id": "sg:person.01003610157.21", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01003610157.21"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "https://doi.org/10.1200/jco.2013.54.8800", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1003708353"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1100/tsw.2011.59", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1024324093"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00259-013-2435-6", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1025772213", 
          "https://doi.org/10.1007/s00259-013-2435-6"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s13139-013-0251-3", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1028298401", 
          "https://doi.org/10.1007/s13139-013-0251-3"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/rlu.0b013e3181f49ab4", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1032669878"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/rlu.0b013e3181f49ab4", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1032669878"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1053/hupa.2002.124723", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1042413909"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2006.09.2403", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1045509899"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1023/a:1008357126404", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1056303423"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/annonc/mdw684", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1059394984"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1258/ar.2011.110123", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1078447639"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1258/ar.2011.110123", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1078447639"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1083044391", 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2018-09", 
    "datePublishedReg": "2018-09-01", 
    "description": "PURPOSE: Plasmablastic lymphoma (PBL) is a rare variant of diffuse large B cell lymphomas (DLBCL) clinically characterized by a poorer prognostic. Few clinical and imaging data are available and derived from pooled case reports and small series. The aim of the study was to evaluate the FDG avidity at baseline and the utility of 18-Fluorodeoxyglucose (FDG) positron-emission-tomography/computed-tomography (PET/CT) for staging and response assessment.\nMETHODS: Patients with newly diagnosed PBL seen at Lymphoma Study Association centers during the period 2005-2015 were included if they underwent a PET/CT at staging and at the end of treatment (eotPET) and had received an anthracycline-based first line therapy. EotPET scans were analyzed using the 5-point-scale visual analysis in accordance with Lugano criteria. Patients were classified in complete metabolic response (CMR) or no-CMR including partial metabolic response (PMR), stable disease (SD) and progression disease (PD). EotPET results were assessed for the ability to predict event free survival (EFS) and overall survival (OS).\nRESULTS: Thirty-five PBL patients fulfilled the inclusion criteria. The median follow-up was 34\u00a0months (2.8-120\u00a0months). FDG avidity was found in all patients at diagnosis. Most patients (80%) achieved CMR, and 20% were no-CMR including 9% PMR, 6% SD, and 6% PD. A CMR after first line chemotherapy predicted higher EFS (p\u2009<\u20090.0001) and OS (p\u2009=\u20090.0006).\nCONCLUSIONS: This study confirmed the FDG avidity of PBL subtype and the usefulness of PET/CT scanning in restaging an aggressive lymphoma at the completion of chemotherapy. EotPET can predict outcomes following treatment in patients with PBL.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1007/s00259-018-4020-5", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1297401", 
        "issn": [
          "1619-7070", 
          "1619-7089"
        ], 
        "name": "European Journal of Nuclear Medicine and Molecular Imaging", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "10", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "45"
      }
    ], 
    "name": "Post-treatment positron emission tomography-computed tomography is highly predictive of outcome in Plasmablastic lymphoma", 
    "pagination": "1705-1709", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "a2716ea000b5d40f88c9e2073c70556718c9cb8b7cfebb25e5ed9ea611c9b962"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "29679112"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "101140988"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s00259-018-4020-5"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1103493485"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s00259-018-4020-5", 
      "https://app.dimensions.ai/details/publication/pub.1103493485"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-11T01:18", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000001_0000000264/records_8697_00000577.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "http://link.springer.com/10.1007%2Fs00259-018-4020-5"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s00259-018-4020-5'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s00259-018-4020-5'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s00259-018-4020-5'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s00259-018-4020-5'


 

This table displays all metadata directly associated to this object as RDF triples.

254 TRIPLES      21 PREDICATES      57 URIs      38 LITERALS      26 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s00259-018-4020-5 schema:about N0e103557b2064f37baaf90aad6bdaba2
2 N2f0317f8483b4d33abfe6d5c442352a3
3 N393ed773c9d44a3e842d3206938f24c3
4 N3c75512f390848f59352b39d29d88652
5 N41b06e8555be414a989249d794f7401f
6 N534720f1b7ec4a2991ca40520d450cf9
7 N61a989e564184b8abb5a6c0a7ecd2e6c
8 N62f90b4606bf43dd8b46df7b76ba0ecb
9 N67df6353632545f0b660f96072d494f4
10 N82037099ead540c9b9003aadfe7c49cb
11 N9a96373cd0d0406a9db8fc3e6148f655
12 Nd08981ecb50b4cdc8809193f0449eea1
13 Nd6dbd83678874a36a2209e75f7c0ca90
14 Nd83f8130adcb48a6bbb2cd61fbb0b25e
15 Nd8dcd47bbbc1438a9f4933db57dc4804
16 Ndc578226d16749efbe54b96fd245f5d2
17 Nee03a4f56e2b469cbc686a28bdaf10bd
18 anzsrc-for:11
19 anzsrc-for:1103
20 schema:author Nfae31417e0e0455497693d9d23d55783
21 schema:citation sg:pub.10.1007/s00259-013-2435-6
22 sg:pub.10.1007/s13139-013-0251-3
23 https://app.dimensions.ai/details/publication/pub.1083044391
24 https://doi.org/10.1023/a:1008357126404
25 https://doi.org/10.1053/hupa.2002.124723
26 https://doi.org/10.1093/annonc/mdw684
27 https://doi.org/10.1097/rlu.0b013e3181f49ab4
28 https://doi.org/10.1100/tsw.2011.59
29 https://doi.org/10.1200/jco.2006.09.2403
30 https://doi.org/10.1200/jco.2013.54.8800
31 https://doi.org/10.1258/ar.2011.110123
32 schema:datePublished 2018-09
33 schema:datePublishedReg 2018-09-01
34 schema:description PURPOSE: Plasmablastic lymphoma (PBL) is a rare variant of diffuse large B cell lymphomas (DLBCL) clinically characterized by a poorer prognostic. Few clinical and imaging data are available and derived from pooled case reports and small series. The aim of the study was to evaluate the FDG avidity at baseline and the utility of 18-Fluorodeoxyglucose (FDG) positron-emission-tomography/computed-tomography (PET/CT) for staging and response assessment. METHODS: Patients with newly diagnosed PBL seen at Lymphoma Study Association centers during the period 2005-2015 were included if they underwent a PET/CT at staging and at the end of treatment (eotPET) and had received an anthracycline-based first line therapy. EotPET scans were analyzed using the 5-point-scale visual analysis in accordance with Lugano criteria. Patients were classified in complete metabolic response (CMR) or no-CMR including partial metabolic response (PMR), stable disease (SD) and progression disease (PD). EotPET results were assessed for the ability to predict event free survival (EFS) and overall survival (OS). RESULTS: Thirty-five PBL patients fulfilled the inclusion criteria. The median follow-up was 34 months (2.8-120 months). FDG avidity was found in all patients at diagnosis. Most patients (80%) achieved CMR, and 20% were no-CMR including 9% PMR, 6% SD, and 6% PD. A CMR after first line chemotherapy predicted higher EFS (p < 0.0001) and OS (p = 0.0006). CONCLUSIONS: This study confirmed the FDG avidity of PBL subtype and the usefulness of PET/CT scanning in restaging an aggressive lymphoma at the completion of chemotherapy. EotPET can predict outcomes following treatment in patients with PBL.
35 schema:genre research_article
36 schema:inLanguage en
37 schema:isAccessibleForFree false
38 schema:isPartOf N546e6c3902024f258ed1ad068c1bf1d9
39 N5dd397901a4b4cf5ba27f4ce94cebce2
40 sg:journal.1297401
41 schema:name Post-treatment positron emission tomography-computed tomography is highly predictive of outcome in Plasmablastic lymphoma
42 schema:pagination 1705-1709
43 schema:productId N681e6f0c26c546d9ab359027af18569d
44 N869364d1546e44dca1b6c500c7561a47
45 Nc0d7ee37411a48f9b5f6cf586baf2914
46 Ncec83a274115418e94c26d00144405ba
47 Nd8365b50618b42beb2c0cff0957493f0
48 schema:sameAs https://app.dimensions.ai/details/publication/pub.1103493485
49 https://doi.org/10.1007/s00259-018-4020-5
50 schema:sdDatePublished 2019-04-11T01:18
51 schema:sdLicense https://scigraph.springernature.com/explorer/license/
52 schema:sdPublisher N6879df0c67f649cd97a865c8af2668f7
53 schema:url http://link.springer.com/10.1007%2Fs00259-018-4020-5
54 sgo:license sg:explorer/license/
55 sgo:sdDataset articles
56 rdf:type schema:ScholarlyArticle
57 N0e103557b2064f37baaf90aad6bdaba2 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
58 schema:name Retrospective Studies
59 rdf:type schema:DefinedTerm
60 N12f58b89de8d499f9a3599e5594a2e5a rdf:first sg:person.01007177364.11
61 rdf:rest Nd4db08b60dae4c20a4c3d5ede0d74e02
62 N22f569550bdf4b3484ccd1c01eab7204 rdf:first sg:person.01326064671.60
63 rdf:rest N23ba02d5068b4c688b4997090b9219bc
64 N23ba02d5068b4c688b4997090b9219bc rdf:first sg:person.01366522606.02
65 rdf:rest Nfc4c42dbf3414e58961ed8a6439793ce
66 N2f0317f8483b4d33abfe6d5c442352a3 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
67 schema:name Aged, 80 and over
68 rdf:type schema:DefinedTerm
69 N320cd5c960ce4f4bb3b7d8bc2db5f755 schema:name Department of Nuclear Medicine, CHU Tenon, Paris, France
70 rdf:type schema:Organization
71 N36884aad123b4b62acbdc5f5a067098e rdf:first sg:person.015715754073.62
72 rdf:rest N12f58b89de8d499f9a3599e5594a2e5a
73 N393ed773c9d44a3e842d3206938f24c3 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
74 schema:name Positron Emission Tomography Computed Tomography
75 rdf:type schema:DefinedTerm
76 N3c75512f390848f59352b39d29d88652 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
77 schema:name Adult
78 rdf:type schema:DefinedTerm
79 N41b06e8555be414a989249d794f7401f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
80 schema:name Male
81 rdf:type schema:DefinedTerm
82 N534720f1b7ec4a2991ca40520d450cf9 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
83 schema:name Plasmablastic Lymphoma
84 rdf:type schema:DefinedTerm
85 N546e6c3902024f258ed1ad068c1bf1d9 schema:issueNumber 10
86 rdf:type schema:PublicationIssue
87 N5dd397901a4b4cf5ba27f4ce94cebce2 schema:volumeNumber 45
88 rdf:type schema:PublicationVolume
89 N61a989e564184b8abb5a6c0a7ecd2e6c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
90 schema:name Fluorodeoxyglucose F18
91 rdf:type schema:DefinedTerm
92 N62f90b4606bf43dd8b46df7b76ba0ecb schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
93 schema:name Prognosis
94 rdf:type schema:DefinedTerm
95 N67df6353632545f0b660f96072d494f4 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
96 schema:name Female
97 rdf:type schema:DefinedTerm
98 N681e6f0c26c546d9ab359027af18569d schema:name readcube_id
99 schema:value a2716ea000b5d40f88c9e2073c70556718c9cb8b7cfebb25e5ed9ea611c9b962
100 rdf:type schema:PropertyValue
101 N6879df0c67f649cd97a865c8af2668f7 schema:name Springer Nature - SN SciGraph project
102 rdf:type schema:Organization
103 N7c17e83b806c4445b9c347d02f1cfd01 rdf:first sg:person.01352532274.15
104 rdf:rest Na803f383624e4e35b09d16af7354dae0
105 N82037099ead540c9b9003aadfe7c49cb schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
106 schema:name Middle Aged
107 rdf:type schema:DefinedTerm
108 N869364d1546e44dca1b6c500c7561a47 schema:name dimensions_id
109 schema:value pub.1103493485
110 rdf:type schema:PropertyValue
111 N9a96373cd0d0406a9db8fc3e6148f655 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
112 schema:name Survival Analysis
113 rdf:type schema:DefinedTerm
114 Na803f383624e4e35b09d16af7354dae0 rdf:first sg:person.012143174115.29
115 rdf:rest N36884aad123b4b62acbdc5f5a067098e
116 Nb72de45eb4924acea06e93a334aa93f4 schema:name Léon Bérard Center, Department of Hematology, Lyon, France
117 rdf:type schema:Organization
118 Nc0d7ee37411a48f9b5f6cf586baf2914 schema:name doi
119 schema:value 10.1007/s00259-018-4020-5
120 rdf:type schema:PropertyValue
121 Ncec83a274115418e94c26d00144405ba schema:name pubmed_id
122 schema:value 29679112
123 rdf:type schema:PropertyValue
124 Nd08981ecb50b4cdc8809193f0449eea1 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
125 schema:name Image Processing, Computer-Assisted
126 rdf:type schema:DefinedTerm
127 Nd4db08b60dae4c20a4c3d5ede0d74e02 rdf:first sg:person.0575401352.69
128 rdf:rest Nff88c08bb745429bb33c2dcc2441c278
129 Nd6dbd83678874a36a2209e75f7c0ca90 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
130 schema:name Humans
131 rdf:type schema:DefinedTerm
132 Nd8365b50618b42beb2c0cff0957493f0 schema:name nlm_unique_id
133 schema:value 101140988
134 rdf:type schema:PropertyValue
135 Nd83f8130adcb48a6bbb2cd61fbb0b25e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
136 schema:name Adolescent
137 rdf:type schema:DefinedTerm
138 Nd8dcd47bbbc1438a9f4933db57dc4804 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
139 schema:name Aged
140 rdf:type schema:DefinedTerm
141 Ndc578226d16749efbe54b96fd245f5d2 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
142 schema:name Young Adult
143 rdf:type schema:DefinedTerm
144 Nee03a4f56e2b469cbc686a28bdaf10bd schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
145 schema:name Treatment Outcome
146 rdf:type schema:DefinedTerm
147 Nf1afb2c5d89e485d90a69030be6aa76a rdf:first sg:person.01003610157.21
148 rdf:rest rdf:nil
149 Nf87d7f59c0384794a256b527add7ab51 schema:name Léon Bérard Center, Department of Hematology, Lyon, France
150 rdf:type schema:Organization
151 Nfae31417e0e0455497693d9d23d55783 rdf:first sg:person.01130727257.14
152 rdf:rest N22f569550bdf4b3484ccd1c01eab7204
153 Nfc4c42dbf3414e58961ed8a6439793ce rdf:first sg:person.0604155154.50
154 rdf:rest N7c17e83b806c4445b9c347d02f1cfd01
155 Nff88c08bb745429bb33c2dcc2441c278 rdf:first sg:person.01370737637.53
156 rdf:rest Nf1afb2c5d89e485d90a69030be6aa76a
157 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
158 schema:name Medical and Health Sciences
159 rdf:type schema:DefinedTerm
160 anzsrc-for:1103 schema:inDefinedTermSet anzsrc-for:
161 schema:name Clinical Sciences
162 rdf:type schema:DefinedTerm
163 sg:journal.1297401 schema:issn 1619-7070
164 1619-7089
165 schema:name European Journal of Nuclear Medicine and Molecular Imaging
166 rdf:type schema:Periodical
167 sg:person.01003610157.21 schema:affiliation https://www.grid.ac/institutes/grid.157868.5
168 schema:familyName Cartron
169 schema:givenName Guillaume
170 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01003610157.21
171 rdf:type schema:Person
172 sg:person.01007177364.11 schema:affiliation https://www.grid.ac/institutes/grid.411167.4
173 schema:familyName Gyan
174 schema:givenName Emmanuel
175 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01007177364.11
176 rdf:type schema:Person
177 sg:person.01130727257.14 schema:affiliation https://www.grid.ac/institutes/grid.157868.5
178 schema:familyName Al Tabaa
179 schema:givenName Yassine
180 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01130727257.14
181 rdf:type schema:Person
182 sg:person.012143174115.29 schema:affiliation https://www.grid.ac/institutes/grid.277151.7
183 schema:familyName Bonnet
184 schema:givenName Antoine
185 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012143174115.29
186 rdf:type schema:Person
187 sg:person.01326064671.60 schema:affiliation https://www.grid.ac/institutes/grid.157868.5
188 schema:familyName Tchernonog
189 schema:givenName Emmanuelle
190 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01326064671.60
191 rdf:type schema:Person
192 sg:person.01352532274.15 schema:affiliation https://www.grid.ac/institutes/grid.411167.4
193 schema:familyName Monjanel
194 schema:givenName Hélène
195 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01352532274.15
196 rdf:type schema:Person
197 sg:person.01366522606.02 schema:affiliation Nb72de45eb4924acea06e93a334aa93f4
198 schema:familyName Faurie
199 schema:givenName Pierre
200 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01366522606.02
201 rdf:type schema:Person
202 sg:person.01370737637.53 schema:affiliation https://www.grid.ac/institutes/grid.157868.5
203 schema:familyName Mariano-Goulart
204 schema:givenName Denis
205 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01370737637.53
206 rdf:type schema:Person
207 sg:person.015715754073.62 schema:affiliation https://www.grid.ac/institutes/grid.277151.7
208 schema:familyName Le Gouill
209 schema:givenName Steven
210 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015715754073.62
211 rdf:type schema:Person
212 sg:person.0575401352.69 schema:affiliation Nf87d7f59c0384794a256b527add7ab51
213 schema:familyName Ghesquieres
214 schema:givenName Hervé
215 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0575401352.69
216 rdf:type schema:Person
217 sg:person.0604155154.50 schema:affiliation N320cd5c960ce4f4bb3b7d8bc2db5f755
218 schema:familyName Cottereau
219 schema:givenName Anne Ségolène
220 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0604155154.50
221 rdf:type schema:Person
222 sg:pub.10.1007/s00259-013-2435-6 schema:sameAs https://app.dimensions.ai/details/publication/pub.1025772213
223 https://doi.org/10.1007/s00259-013-2435-6
224 rdf:type schema:CreativeWork
225 sg:pub.10.1007/s13139-013-0251-3 schema:sameAs https://app.dimensions.ai/details/publication/pub.1028298401
226 https://doi.org/10.1007/s13139-013-0251-3
227 rdf:type schema:CreativeWork
228 https://app.dimensions.ai/details/publication/pub.1083044391 schema:CreativeWork
229 https://doi.org/10.1023/a:1008357126404 schema:sameAs https://app.dimensions.ai/details/publication/pub.1056303423
230 rdf:type schema:CreativeWork
231 https://doi.org/10.1053/hupa.2002.124723 schema:sameAs https://app.dimensions.ai/details/publication/pub.1042413909
232 rdf:type schema:CreativeWork
233 https://doi.org/10.1093/annonc/mdw684 schema:sameAs https://app.dimensions.ai/details/publication/pub.1059394984
234 rdf:type schema:CreativeWork
235 https://doi.org/10.1097/rlu.0b013e3181f49ab4 schema:sameAs https://app.dimensions.ai/details/publication/pub.1032669878
236 rdf:type schema:CreativeWork
237 https://doi.org/10.1100/tsw.2011.59 schema:sameAs https://app.dimensions.ai/details/publication/pub.1024324093
238 rdf:type schema:CreativeWork
239 https://doi.org/10.1200/jco.2006.09.2403 schema:sameAs https://app.dimensions.ai/details/publication/pub.1045509899
240 rdf:type schema:CreativeWork
241 https://doi.org/10.1200/jco.2013.54.8800 schema:sameAs https://app.dimensions.ai/details/publication/pub.1003708353
242 rdf:type schema:CreativeWork
243 https://doi.org/10.1258/ar.2011.110123 schema:sameAs https://app.dimensions.ai/details/publication/pub.1078447639
244 rdf:type schema:CreativeWork
245 https://www.grid.ac/institutes/grid.157868.5 schema:alternateName University Hospital of Montpellier
246 schema:name Department of Hematology, University Hospital of Montpellier, UMR CNRS 5235, Montpellier, France
247 Department of Nuclear Medicine, CHU Montpellier, 80 Avenue Augustin Fliche, 34095, Montpellier, Cedex 05, France
248 rdf:type schema:Organization
249 https://www.grid.ac/institutes/grid.277151.7 schema:alternateName Centre Hospitalier Universitaire de Nantes
250 schema:name Department of Hematology, University Hospital of Nantes, INSERM UMR 892, Nantes, France
251 rdf:type schema:Organization
252 https://www.grid.ac/institutes/grid.411167.4 schema:alternateName Centre Hospitalier Universitaire de Tours
253 schema:name Department of Hematology, University Hospital of Tours, Tours, France
254 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...